AS

Andrew Smith

Quality Control Analyst III at Alnylam Pharmaceuticals

Andrew Smith is currently serving as a Quality Control Analyst III at Alnylam Pharmaceuticals, where responsibilities include supporting Raw Materials, Microbiology, and Analytical teams through the performance of routine and non-routine analytical and microbiological assays. Previously, Andrew worked as an Associate II in Quality Control at Moderna, demonstrating proficiency in HPLC and other quality assurance methodologies, and as a QC Analyst at Amgen, utilizing compendial and internal methods to ensure material quality. Prior experience includes a Lab Technician role at Eurofins, focusing on pathogen testing in a GMP environment, and an Aquatics Specialist position at Petco, providing customer service and care for aquatic systems. Andrew holds a Bachelor of Arts in Marine Biology and Sustainability Studies from Roger Williams University, complemented by studies at the Bermuda Institute of Ocean Sciences.

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


Alnylam Pharmaceuticals

31 followers

Alnylam is the world's leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market.


Industries

Employees

1,001-5,000

Links